Shinpoong Pharmaceutical Co.,Ltd (KRX:019175)

South Korea flag South Korea · Delayed Price · Currency is KRW
26,550
+200 (0.76%)
At close: Aug 14, 2025, 3:30 PM KST
0.76%
Market Cap727.88B
Revenue (ttm)222.50B
Net Income (ttm)-13.49B
Shares Outn/a
EPS (ttm)-263.13
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume9,615
Average Volume12,918
Open25,900
Previous Close26,350
Day's Range25,750 - 26,550
52-Week Range9,650 - 55,000
Beta1.46
RSI53.86
Earnings DateAug 14, 2025

About KRX:019175

Shinpoong Pharmaceutical Co.,Ltd, together with its subsidiaries, manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products, as well as antivirals, anticancer drugs, painkillers, anti-inflammatory products, and anthelmintics. It provides active pharmaceutical ingredients; Pyramax, an anti-malarial drug; and drugs for treating hypercholesterolemia, knee osteoarthritis and shoulder periarthritis, and surgical adhesion barrier; prescription drugs; woun... [Read more]

Sector Healthcare
Founded 1962
Employees 819
Stock Exchange Korea Stock Exchange
Ticker Symbol 019175
Full Company Profile

Financial Performance

In 2024, KRX:019175's revenue was 221.09 billion, an increase of 10.42% compared to the previous year's 200.23 billion. Losses were -14.82 billion, -74.15% less than in 2023.

Financial Statements

News

There is no news available yet.